0001840229 2026-08-13 2026-08-13 0001840229 1 2026-08-13 2026-08-13 0001840229 2 2026-08-13 2026-08-13 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001840229 MiNK Therapeutics, Inc. N/A false false S-8 MiNK Therapeutics, Inc. Equity Common stock, $0.00001 par value per share true 188249 11.25 2117801.25 0.0001381 292.47 Equity Common stock, $0.00001 par value per share true 47062 11.25 529447.50 0.0001381 73.12 2647248.75 365.59 0.00 365.59 (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers such additional shares of MiNK Therapeutics, Inc.'s (the "Registrant's") common stock, par value $0.00001 per share ("Common Stock"), as may be issued to prevent dilution from stock splits, stock dividends and similar transactions. (2) Consists of 188,249 shares of the Registrant's Common Stock that became available for issuance on January 1, 2026 under the Registrant's 2021 Equity Incentive Plan (the "2021 EIP") resulting from the annual "evergreen" increase in the number of authorized shares reserved and available for issuance under the 2021 EIP on January 1, 2026. (3) Estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) and 457(h), based on the average of the high and low prices of the Registrant's Common Stock as reported on the Nasdaq Capital Market on August 11, 2026. (4) The Registrant does not have any fee offsets. (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers such additional shares of MiNK Therapeutics, Inc.'s (the "Registrant's") common stock, par value $0.00001 per share ("Common Stock"), as may be issued to prevent dilution from stock splits, stock dividends and similar transactions. (2) Consists of 47,062 shares of the Registrant's Common Stock that became available for issuance under the Registrant's 2021 Employee Stock Purchase Plan (the "2021 ESPP") resulting from the annual "evergreen" increase in the number of authorized shares reserved and available for issuance under the 2021 ESPP on January 1, 2026. (3) Estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) and 457(h), based on the average of the high and low prices of the Registrant's Common Stock as reported on the Nasdaq Capital Market on August 11, 2026. (4) The Registrant does not have any fee offsets.